The HIV/AIDS study group, Research Center on Global Emerging and Re-emerging Infectious Diseases, Institute of Tropical Disease Universitas Airlangga, successfully held a Coordination Meeting for the Preparation of a Policy Brief with the topic “The Role of Antiretroviral Resistance Examination as an Effort to Control the Number of HIV Cases in Indonesia.” This activity was held at the Swiss Bellin Hotel, Manyar Surabaya, on Wednesday, August 24, 2022. It was attended by a great resource person, Prof. Dr. Nasronudin, dr., Sp.PD., KPTI-FINASIM as the director of Airlangga Hospital, and Prof. Maria Inge Lusida, dr., M.Kes., Ph.D., Sp.MK as the director of ITD.

This coordination meeting was also attended by clinicians, researchers, and policymakers. The purpose of this activity is to disseminate the analysis of data obtained from molecular epidemiological surveillance in the analysis of HIV genotype (subtype and ARV resistance), increase early detection efforts (subtypes and resistance) in HIV patients for successful therapy, and as a reference in selecting the right ARV, and to reduce cases of transmission of resistant HIV.

The results of molecular epidemiological surveillance research data related to ARV resistance information are expected to become a new policy in HIV/AIDS prevention to support the achievement of the SDGs targets in the field of HIV/AIDS infection, namely to end AIDS epidemic by 2030.